ACTG Publications

TitleAuthorsDateJournalIssueVolume
Higher expression of several interferon-stimulated genes in HIV-1-infected females after adjusting for the level of viral replication.Chang, J Judy ; Woods, Matt ; Lindsay, Robert J ; Doyle, Erin H ; Griesbeck, Morgane ; Chan, Ellen S ; Robbins, Gregory K ; Bosch, Ronald J ; Altfeld, Marcus2013 Sep 1J Infect Dis5208
HIV peripheral neuropathy progression: protection with glucose-lowering drugs?Evans, Scott R ; Lee, Anthony J ; Ellis, Ronald J ; Chen, Huichao ; Wu, Kunling ; Bosch, Ronald J ; Clifford, David B2012 OctJ Neurovirol518
HIV-1 amino acid changes among participants with virologic failure: associations with first-line efavirenz or atazanavir plus ritonavir and disease status.Mollan, Katie ; Daar, Eric S ; Sax, Paul E ; Balamane, Maya ; Collier, Ann C ; Fischl, Margaret A ; Lalama, Christina M ; Bosch, Ronald J ; Tierney, Camlin ; Katzenstein, David ; AIDS Clinical Trials Group Study A5202 Team2012 Dec 15J Infect Dis12206
HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy.Besson, Guillaume J ; Lalama, Christina M ; Bosch, Ronald J ; Gandhi, Rajesh T ; Bedison, Margaret A ; Aga, Evgenia ; Riddler, Sharon A ; McMahon, Deborah K ; Hong, Feiyu ; Mellors, John W2014 Nov 1Clin Infect Dis959
HIV-1 RNA levels and antiretroviral drug resistance in blood and non-blood compartments from HIV-1-infected men and women enrolled in AIDS clinical trials group study A5077.Kantor, Rami ; Bettendorf, Daniel ; Bosch, Ronald J ; Mann, Marita ; Katzenstein, David ; Cu-Uvin, Susan ; D'Aquila, Richard ; Frenkel, Lisa ; Fiscus, Susan ; Coombs, Robert ; ACTG A5077 Study Team2014PLoS One49